Catalio Capital closes over $400M Fund IV

Venture Capital Company Catalo Capital Management Announced today Closing more than $ 400 million, As reported first by Bloomberg. The Fund will continue the thesis of the company to support shareholder and biotechnology companies.

The company was established in 2020 and invested in more than 100 investments. In particular, the Catalio Foundation, especially diagnostic company PinkDX and drug discovery, supported 16 companies, including Superluminal Medicine.

The company previously had a $ 381 million Foundation in 2020 and in 2019 in 2019, the United States of 19 million dollars in 2019, $ 381 million in the Pitchbook.

Especially in the biotechnic market, the higherment of the last year, higher interest rates and the refrigerator IPO market followed. The section increased a total of $ 12 billion in the summit of $ 12 billion in the summit of $ 12 billion, as soon as Bloomberg said.